A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

Zhang, Yiqun, Kwok-Shing Ng, Patrick, Kucherlapati, Melanie, Chen, Fengju, Liu, Yuexin, Tsang, Yiu Huen, de Velasco, Guillermo, Jeong, Kang Jin +34 more·2017·Cancer Cell

Cited by (645)

Items 501–600 of 645

  1. Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples
    Nicola Calonaci, Eriseld Krasniqi, Daniel Colic, Stefano Scalera, Giorgia Gandolfi, Salvatore Milite, Konstantin Bräutigam, Andrea Sottoriva, Trevor A. Graham, Leonardo Egidi et al. · 2026 · Nature Genetics
  2. Congenital infiltrating lipomatosis of the face: Case report
    Ghita Lahnine, Fatima Saddouki, Zineb Bouanani, Amal Akammar, Nizar El Bouardi, Meriem Haloua, Badreeddine Alami, Youssef A. Lamrani, Mustapha Maâroufi, Meriem Boubbou · 2024 · Radiology Case Reports
  3. ZDOG: zooming in on dominating genes with mutations in cancer pathways
    Rudi Alberts, Jinyu Chen, Louxin Zhang · 2019 · BMC Bioinformatics
  4. Metabolic Oxidative Stress in Initiation, Progression, and Therapy of Cancer
    Soumen Bera, Amit Verma, Anant Narayan Bhatt, Bilikere Srinivasa Rao Dwarakanath · 2022 · Springer eBooks
  5. A Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of Cancer
    Afshin Derakhshani, Zeinab Rostami, Hossein Safarpour, Sina Taefehshokr, Neda Jalili Tabrizi, Mahdi Abdoli Shadbad, Omid Kooshkaki, Reza Vaezi Astamal, Antonella Argentiero, Pankaj K. Singh et al. · 2020 · Preprints.org
  6. Aspirin Regulates Gemcitabine Resistance in Pancreatic Cancer via Inhibiting the PI3K/Akt/mTOR Signaling Pathway and Reversing Epithelial-mesenchymal Transition
    Hanyu Zhou, Zhiying Yan, Feifei Wei, Muhan Liu, yi liu, Xianming Zhang, Kequn xu, Yingwei Zhu, Yun Xiao · 2021 · Research Square
  7. Long noncoding RNA UCA1 facilitates cell proliferation and inhibits apoptosis via activating PI3K/Akt pathway in retinoblastoma
    Zhongfang Yuan, Zhaona Li · 2019 · Research Square
  8. Chemical composition and pharmacological mechanism of Ephedra-Glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19)
    Qin Qiu, Mingyue Li, Haowen Lin, Shilin Cao, Qu Wang, Xiaoling Li, Zishi Chen, Wenhao Jiang, Yuge Huang, Hui Luo et al. · 2020 · Research Square
  9. The Eukaryotic mRNA Cap Structure
    Jerry Pelletier, Nahum Sonenberg · 2023 · Encyclopedia of Life Sciences
  10. Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells
    Artem D. Berezovsky, Oluwademilade Nuga, Indrani Datta, Kimberly Bergman, Thaís S. Sabedot, Katherine Gurdziel, Susan M. Irtenkauf, Laura A. Hasselbach, Yuling Meng, Claudius Mueller et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  11. MAGE-A4-Responsive Plasma Cells Promote Non-Small Cell Lung Cancer
    Dominique Armstrong, Cheng-Yen Chang, M J Hong, Linda Green, William Hudson, Yichao Shen, Lizhen Song, Sheetal Jammi, Benjamin Casal, Chad J. Creighton et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  12. PI3K/mTOR activity sensitizes cancer cells to nucleolar stress
    Myriam Barz, Alba Corman, Maria Häggblad, Alicia Gonzalez-Serrano, Louise Lidemalm, Matilde Murga, Daniela Hühn, Óscar Fernández-Capetillo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Human Kinome In Skeletal Muscle Insulin Resistance
    Yue Andy Qi · 2017 · Human Biology
  14. Opportunities and Resistance to Signal-Targeted Therapies in Pancreatic Cancer: What Can we Learn from Proteomic Studies?
    Célia Cintas, Thibaut Douché, Julie Guillermet‐Guibert · 2018 · Preprints.org
  15. Quantitative Proteomics to Support Translational Cancer Research
    Melissa A. Hoffman · 2018 · Digital Commons - University of South Florida (University of South Florida)
  16. The lipid kinase PI3Kα is required for the cohesion and survival of cancer cells disseminated in serous cavities
    Benoît Thibault, A Thole, Céline Basset, Julie Guillermet‐Guibert · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Biology of Pancreas and Possible Diseases
    Gowru Srivani, Begum Dariya, Batoul Farran, Afroz Alam, Ganji Purnachandra Nagaraju · 2019 · Springer eBooks
  18. Comprehensive and Integrated Genomic Characterization of Human Immunome in Cancer
    Yongsheng Li, Todd Triplett, Brandon Burgman, Ming Sun, Daniel James McGrail, Dan Qi, Sachet Ashok Shukla, Erxi Wu, Catherine J. Wu, Anna Capasso et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Peer Review #3 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"
    2020 · PeerJ
  20. Peer Review #3 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"
    2020 · PeerJ
  21. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer
    Mohammad Askandar Iqbal, Shumaila Siddiqui, Asad Ur Rehman, Farid Ahmad Siddiqui, Prithvi Singh, Bhupender Kumar, Daman Saluja · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Discovery of novel putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in AML cells
    W. Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, Megan McLaughlin, Audrey L Griffith, Annabel K Sangree, Marissa N Feeley, Nazanin Esmaeili Anvar, Eiru Kim, Lori L Bertolet et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. MiR-186 serves as a tumor suppressor in lung adenocarcinoma cells by down-regulation of Shp2 gene and inhibiting PI3K/Akt/mTOR signaling pathway
    Shaohui Yan, Shufeng Xu, Lei Zheng, Liying Kang, Jun-Li Cao, Ping Wang, Liming Gao · 2020
  24. Metabolic Oxidative Stress in Initiation, Progression, and Therapy of Cancer
    Soumen Bera, Amit Verma, Anant Narayan Bhatt, Bilikere Srinivasa Rao Dwarakanath · 2021 · Springer eBooks
  25. EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Formation
    Nannan Zhu, Qian Hui Wang, Zhidong Wu, Yan Wang, Mu‐Sheng Zeng, Yan Yuan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  26. The HuoXue DiTan Recipe Attenuates Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats by Increasing Autophagy Through the PTEN/PI3K/AKT/mTOR Pathway
    Jiamei Yao, Cui Zhang, YANG Yushu, YANG Haiyan, Dan Zhang, SHI Yongyue, Qiong Chen, Guangwei Zhong · 2021 · Research Square
  27. M058 Effects of Technical Vocabulary Knowledge on Academic Writing : A Research Article Translation Task(CHALLENGES FOR TERTIARY ENGLISH EDUCATION-JACET's Role in the next Fifty Years)
    David J. Dalsky · 2011 · JACET全国大会要綱
  28. Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 Dysregulation
    Juan María Roldán‐Romero, María Santos, Javier Lanillos, Pablo Maroto, Geòrgia Anguera, Bruna Calsina, Ángel M. Martínez‐Montes, María Monteagudo, Sara Mellid, Luis Javier Leandro-Garcia et al. · 2021 · Research Square
  29. Proteome dynamics under proteotoxic stress and disease
    Kevin Klann · 2021
  30. Systematic Pan-Cancer Analysis Reveals Molecular Characteristics and Clinical Relevance of Serine/Arginine-Rich Splicing Factors in Human Cancers
    Congkuan Song, Jinjin Zhang, Shize Pan, Bo Hao, Ruyuan He, Heng Meng, Donghang Li, Kai Lai, Ning Li, Qing Geng · 2022 · SSRN Electronic Journal
  31. Peer Review #2 of "Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma (v0.1)"
    2021 · PeerJ
  32. Peer Review #1 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"
    2020 · PeerJ
  33. Peer Review #1 of "Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma (v0.1)"
    2021 · PeerJ
  34. Peer Review #1 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"
    2020 · PeerJ
  35. Peer Review #2 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"
    2020 · PeerJ
  36. Opportunities and Resistance to Signal-targeted Therapies in Pancreatic Cancer: What Can We Learn from Proteomic Studies?
    Célia Cintas, Thibaut Douché, Julie Guillermet‐Guibert · 2018 · Preprints.org
  37. The Lipid Kinase PI3Kα is Required for the Cohesion and Survival of Cancer Cells Disseminated in Serous Cavities
    Benoît Thibault, Adrien Thole, Céline Basset, Julie Guillermet‐Guibert · 2021 · SSRN Electronic Journal
  38. Peer Review #2 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"
    2020 · PeerJ
  39. Faculty Opinions recommendation of Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
    David Fruman · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  40. KAT8 promotes the resistance of human NSCLC cells to miR-7 intervention via the H4K16/PAX6 axis
    Jing Yang, Xu Zhao, Dongmei Li, Lin Tang, Wen Zheng, Longqinq Chen, Jing Chen, Chao Chen, Ming Qin, Mengmeng Guo et al. · 2022 · Research Square
  41. Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome
    Thiago Vidotto, Camila Morais Melo, William Lautert-Dutra, LP Chaves, RB Reis, Jeremy Andrew Squire · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Low FBXL7 Expression Indicates Low Overall Survival in Bladder Cancer
    Qier Xia, Xinyue Hu, Jun Li, Yifan Shen, Haibin Wei, Jing Qian, Dahong Zhang · 2022 · Research Square
  43. Prevalencia de la mutación de PIK3CA en cáncer de mama en la Argentina y su asociación con variables clínico-patológicas
    Pablo Mandó, Rosario Vidal, Ana Alonso, Celia Brosio, Gonzalo Recondo, Gabriel Crimi, Francisco Von Stecher, Valeria Dennighoff, Florencia Perazzo · 2022 · Oncología Clínica
  44. Data from Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation
    Brian D. Yard, Priyanka Gopal, Kristina Bannik, Gerhard Siemeister, Urs B. Hagemann, Mohamed E. Abazeed · 2023
  45. Data from Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation
    Brian D. Yard, Priyanka Gopal, Kristina Bannik, Gerhard Siemeister, Urs B. Hagemann, Mohamed E. Abazeed · 2023
  46. Data from Integrated Genomic Characterization of the Human Immunome in Cancer
    Yongsheng Li, Brandon Burgman, Daniel James McGrail, Ming Hua Sun, Dan Qi, Sachet Ashok Shukla, Erxi Wu, Anna Capasso, Shiaw‐Yih Lin, Catherine J. Wu et al. · 2023
  47. Supplementary Methods from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
    Komal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
  48. Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
    Komal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
  49. Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
    Komal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
  50. Supplementary Figure 2 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
    Ximena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, Albert J.H. Suurmeijer, Jourik A. Gietema, Marcel A.T.M. van Vugt, Steven de Jong · 2023
  51. Principles of PI 3K Biology and Its Role in Lymphoma
    Ralitsa Radostinova Madsen · 2023 · Wiley eBooks
  52. Meat enriched-diet and inflammation promote PI3Kα-dependent pancreatic cell plasticity that limit tissue regeneration
    Coralie Cayron, Dimitra Bozoglou, Amélie V. Villard, Gabriela Reyes‐Castellanos, N Therville, Romain Baer, Silvia Arcucci, Nathalie Naud, Marie Tosolini, Frédéric Pont et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T-cell receptors for cancer immunotherapy targeting hotspot driver mutations
    Aishun Jin, Meiying Shen, Siyin Chen, Xiaojian Han, Yanan Hao, Li Luo, Tong Chen, Bozhi Wang, Lin Zou, Junfan Wang et al. · 2023 · Research Square
  54. Low MYCT1 expression is an independent prognostic predictor and MYCT1 upregulation can induce oral squamous cell carcinoma development
    Yuanyuan Xie, Jing He, Wenmin An, Zhenning Li · 2023 · Research Square
  55. Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population
    Subhajit Malakar, Srilagna Chatterjee, Madhusudhan Das, Dilip Kumar Pal · 2024 · Urologia Journal
  56. Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy
    Mohsen Aliakbarian, Gordon A. Ferns, Mahmoud Mohamadzadeh Shabestari, Amir Mahmoud Ahmadzadeh, Aref Abdollahzade, Hoda Rahimi, Rozita Khodashahi, Mohammad‐Hassan Arjmand · 2024 · Current Cancer Drug Targets
  57. Additional file 3 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  58. Additional file 9 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  59. Additional file 4 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  60. Additional file 2 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  61. Additional file 11 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  62. Additional file 6 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  63. Additional file 10 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  64. Additional file 7 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  65. Additional file 5 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Xiaoli Ma, Xiaomeng Xie, Bingbing Lu, Kyle Vaughn Laster, Kangdong Liu, Zigang Dong, Dong Joon Kim · 2020 · Figshare
  66. Additional file 8 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  67. Additional file 1 of The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
    Bisheng Cheng, Lingfeng Li, Yongxin Wu, Tianlong Luo, Chen Tang, Qiong Wang, Qianghua Zhou, Jilin Wu, Yiming Lai, Dingjun Zhu et al. · 2023 · Figshare
  68. Additional file 5 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
  69. Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomics
    Kai Fan, Yueyuan Wang, Jiangyujing Bian, Yewen Sun, Jiaqi Dou, Jie Pan, Yunli Yu · 2024 · Investigational New Drugs
  70. Treatments that Target Cell Communication
    Elaine Vickers · 2024
  71. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
    Fengchao Yin, Fang Li, Qi Pan, Aili Zhang · 2024 · Open Life Sciences
  72. Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma
    Marina Pérez-Capó, Esther Martinez-Font, Elena Prados, Rafael Ramos, Raúl Sánchez Morillas, Maria Rosa Martorell, Oliver Vögler, Regina Alemany, Antònia Obrador‐Hevia · 2025 · Pathobiology
  73. An exposure–safety analysis to support the dosage of the novel AKT inhibitor capivasertib
    Carlos Fernández Teruel, Marie Cullberg, Ignacio González-García, Gaia Schiavon, Diansong Zhou · 2025 · Cancer Chemotherapy and Pharmacology
  74. Integrated functional genomics-identified LYRM4 promotes fumarate accumulation and hepatocellular carcinoma progression
    Yuan Xu, Yanting Yang, Xinyuan Yu, Linyu Han, Shuqing Liu, Nasha Zhang, Ming Yang · 2025 · Archives of Biochemistry and Biophysics
  75. An Overview of Analytical Approaches to Cancer Proteogenomics
    Chad J. Creighton · 2025 · Methods in molecular biology
  76. Molecular Subtyping and Classification of PIK3CA Mutations in Metastatic Breast Cancer
    Amrit Kaur Kaler, Manish M Jethani, Mandar S. Nadkarni, Yash Tiwarekar, Varsha Balaji, Tanmay Wairkar, Bijal N. Kulkarni, Nevitha Athikari, Shalaka Satpute, Ratika Agarwal et al. · 2025 · Current Tissue Microenvironment Reports
  77. Kanser Tedavisinde PI3K/AKT/mTOR Yolunun Hedeflenmesi: Yeni Nesil mTOR İnhibitörlerine Güncel Bir Değerlendirme
    Erhan Aptullahoğlu · 2025 · Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi
  78. NRF2 Dysregulation and Its Implications in Renal Cell Carcinoma
    Bumjun Jang, Mi‐Kyoung Kwak · 2025 · Drug Targets and Therapeutics
  79. Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study
    Suchit R. Geereddy, Amber L. Chang, Alma Gallegos, Jonathan T. Lin, Akaash Surendra, Suraj Puvvadi, Beau Hsia, Abubakar Tauseef, Joseph Thirumalareddy, Akshat Sood · 2025 · Cancers
  80. Molecular approach of renal cell carcinoma using FISH method : a prospective study (23 cases) and state of the art
    Rafik BEN TAYEB, Mohammed Mzyiene, Nizar BOUARDI, Fatimazahra FARHANE, Touria BOUHAFA, Laila Bouguenouch, Nawfel MELLAS, Mustapha MAAROUFI, Moulay Hassan FARIH, hinde el fatemi · 2022 · Research Square
  81. Additional file 1 of ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
    Chen, Han, 王恒孝, Xiqiao Yu, Zhou, Shuping, Zhang, Yueying, Wang, Zhaopeng, Huang, Shuhong, ZHAOXIA WANG · 2020 · Figshare
  82. Additional file 12 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  83. Additional file 9 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  84. Additional file 1 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer
    Deyu Long, Zhang, Ruiqi, Du, Changjian, Jiapei Tong, Ni, Yu, Zhou, Yaqi, Zuo, Yongchun, Liao, Mingzhi · 2023 · Figshare
  85. Additional file 4 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  86. Additional file 4 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness
    Matilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
  87. Additional file 5 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  88. Additional file 11 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  89. Additional file 7 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness
    Matilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
  90. Additional file 6 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Ma, Xiaoli, Xie, Xiaomeng, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
  91. Additional file 1 of Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds
    Claire Blanchard, Alison Gomeiz, Kyle Avery, Gazzah, Emna El, Abduljalil M. Alsubaie, Masoumeh Sikaroodi, Ylenia Chiari, Chelsea Ward, Sanchez, Jonathan, Virginia A. Espina et al. · 2024 · Figshare
  92. Additional file 2 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  93. Additional file 1 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  94. Additional file 6 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness
    Matilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
  95. Additional file 13 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer
    Ma, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
  96. Additional file 7 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
  97. Additional file 2 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
  98. Additional file 1 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Ma, Xiaoli, Xie, Xiaomeng, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
  99. Additional file 3 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
    Xueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
  100. Additional file 1 of Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis
    Wang, Ting, Sun, Longci, Chengkun Chen, Zhang, Yingchao, He, Baoyu, Zhang, Yanhua, Zhenghe Wang, Hanbing Xue, Hao, Yujun · 2023 · Figshare